Asia-pacific Male Infertility Market 2023-2030

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $1,500	123 Pages	Triton Market Research	July, 2023	TRTN18073100

Best Price Guarantee
Price	from $1,500
Length	123 Pages
Publisher	Triton Market Research
Published Date	July, 2023
SKU	TRTN18073100

Asia-pacific Male Infertility Market 2023-2030

MARKET OUTLOOK

Triton’s research report on the Asia-Pacific male infertility market states that the market is projected to progress with a CAGR of 5.38% during the forecast period 2023-2030. India, South Korea, China, Japan, Australia & New Zealand, ASEAN countries, and Rest of Asia-Pacific are studied in the region’s report.

In India, the male infertility market is experiencing significant growth due to increasing awareness about infertility, leading to a higher demand for effective treatments. Male infertility accounts for almost 50% of infertility cases in India, with a prevalence rate of 23%, according to the World Health Organization. This decline in sperm count increased the need for treatments, which may generate opportunities for the male infertility market in the country.

During the forecast period, the male infertility market in South Korea is expected to grow due to significant lifestyle changes, a higher incidence of diseases like diabetes, and increased utilization of assisted reproductive technologies (ARTs). According to the National Center for Biotechnology Information, in 2020, diabetes mellitus affected around 16.7% of the population. Hence, all these factors widen the scope and growth of the studied market.

COMPETITIVE OUTLOOK

The leading companies in the male infertility market comprise Vitrolife, Bayer AG, Aytu BioPharma, Zydus Lifesciences Limited, and CinnaGen Co.

1. Asia-pacific Male Infertility Market - Summary
2. Industry Outlook: 2.1. Parent Market Analysis; 2.2. Impact Analysis On The Male Infertility Market; 2.2.1. Covid-19 Impact; 2.2.2. Ukraine-russia War Impact; 2.3. Porter’s Five Forces Analysis; 2.3.1. Threat Of New Entrants; 2.3.2. Threat Of Substitutes; 2.3.3. Bargaining Power Of Buyers; 2.3.4. Bargaining Power Of Suppliers; 2.3.5. Threat Of Competitive Rivalry; 2.4. Market Maturity Analysis; 2.5. Key Market Strategies; 2.5.1. Collaborations; 2.5.2. Product Launches; 2.5.3. Mergers & Acquisitions; 2.5.4. Business Divestitures & Expansions; 2.6. Market Drivers; 2.6.1. Prevalence Of Infertility; 2.6.2. Use Of Assisted Reproductive Technologies; 2.6.3. Technological Innovations And Advancements; 2.7. Market Challenge; 2.7.1. High Cost Of Treatment; 2.8. Market Opportunities; 2.8.1. Increasing Acceptance Of Minimally Invasive Surgeries; 2.8.2. Growing Availability Of Infertility Treatment Drugs, Procedures, And Devices; 2.8.3. Government Initiatives Toward Improving Reimbursement Policies; 2.9. Analyst Perspective
3. Asia-pacific Male Infertility Market – By Test Type: 3.1. Dna Fragmentation Technique; 3.2. Oxidative Stress Analysis; 3.3. Microscopic Examination; 3.4. Sperm Agglutination; 3.5. Computer-assisted Semen Analysis; 3.6. Sperm Penetration Assay; 3.7. Other Test Types
4. Asia-pacific Male Infertility Market – By Treatment: 4.1. Assisted Reproductive Technology And Surgery; 4.2. Medications
5. Asia-pacific Male Infertility Market – By Country Outlook: 5.1. Country Analysis; 5.1.1. China; 5.1.1.1. China Male Infertility Market Forecast & Prospects; 5.1.2. Japan; 5.1.2.1. Japan Male Infertility Market Forecast & Prospects; 5.1.3. India; 5.1.3.1. India Male Infertility Market Forecast & Prospects; 5.1.4. South Korea; 5.1.4.1. South Korea Male Infertility Market Forecast & Prospects; 5.1.5. Asean Countries; 5.1.5.1. Asean Countries Male Infertility Market Forecast & Prospects; 5.1.6. Australia & New Zealand; 5.1.6.1. Australia & New Zealand Male Infertility Market Forecast & Prospects; 5.1.7. Rest Of Asia-pacific; 5.1.7.1. Rest Of Asia-pacific Male Infertility Market Forecast & Prospects
6. Competitive Landscape: 6.1. Halotech Dna; 6.1.1. Overview; 6.1.2. Product Portfolio; 6.2. Emd Serono Inc; 6.2.1. Overview; 6.2.2. Product Portfolio; 6.2.3. Key Strengths; 6.2.4. Key Challenges; 6.3. Endo International Plc; 6.3.1. Overview; 6.3.2. Product Portfolio; 6.3.3. Key Strengths; 6.3.4. Key Challenges; 6.4. Vitrolife; 6.4.1. Overview; 6.4.2. Product Portfolio; 6.4.3. Key Strengths; 6.4.4. Key Challenges; 6.5. Bayer Ag; 6.5.1. Overview; 6.5.2. Product Portfolio; 6.5.3. Key Strengths; 6.5.4. Key Challenges; 6.6. Aytu Biopharma; 6.6.1. Overview; 6.6.2. Product Portfolio; 6.6.3. Key Strengths; 6.6.4. Key Challenges; 6.7. Zydus Lifesciences Limited; 6.7.1. Overview; 6.7.2. Product Portfolio; 6.7.3. Key Strengths; 6.7.4. Key Challenges; 6.8. Cinnagen Co; 6.8.1. Overview; 6.8.2. Product Portfolio; 6.8.3. Key Strengths; 6.8.4. Key Challenges; 6.9. Sanofi Sa; 6.9.1. Overview; 6.9.2. Product Portfolio; 6.9.3. Key Strengths; 6.9.4. Key Challenges; 6.10. Laboratory Corporation Of America Holdings; 6.10.1. Overview; 6.10.2. Product Portfolio; 6.10.3. Key Strengths; 6.10.4. Key Challenges
7. Research Methodology & Scope: 7.1. Research Scope & Deliverables; 7.2. Sources Of Data; 7.3. Research Methodology
Table List: Table 1: Asia-pacific Male Infertility Market, By Country Outlook, 2023-2030 (In $ Million); Table 2: List Of Collaborations; Table 3: List Of Product Launches; Table 4: List Of Mergers & Acquisitions; Table 5: List Of Business Divestitures & Expansions; Table 6: Asia-pacific Male Infertility Market, By Test Type, 2023-2030 (In $ Million); Table 7: Asia-pacific Male Infertility Market, By Treatment, 2023-2030 (In $ Million); Table 8: Asia-pacific Male Infertility Market, By Country Outlook, 2023-2030 (In $ Million)
Figure List: Figure 1: Market Maturity Analysis; Figure 2: Asia-pacific Male Infertility Market, By Type, 2022 & 2030 (In %); Figure 3: Asia-pacific Male Infertility Market, By Dna Fragmentation Technique, 2023-2030 (In $ Million); Figure 4: Asia-pacific Male Infertility Market, By Oxidative Stress Analysis, 2023-2030 (In $ Million); Figure 5: Asia-pacific Male Infertility Market, By Microscopic Examination, 2023-2030 (In $ Million); Figure 6: Asia-pacific Male Infertility Market, By Sperm Agglutination, 2023-2030 (In $ Million); Figure 7: Asia-pacific Male Infertility Market, By Computer-assisted Semen Analysis, 2023-2030 (In $ Million); Figure 8: Asia-pacific Male Infertility Market, By Sperm Penetration Assay, 2023-2030 (In $ Million); Figure 9: Asia-pacific Male Infertility Market, By Other Test Types, 2023-2030 (In $ Million); Figure 10: Asia-pacific Male Infertility Market, By Treatment, 2022 & 2030 (In %); Figure 11: Asia-pacific Male Infertility Market, By Assisted Reproductive Technology And Surgery, 2023-2030 (In $ Million); Figure 12: Asia-pacific Male Infertility Market, By Medications, 2023-2030 (In $ Million); Figure 13: Asia-pacific Male Infertility Market, By Country Outlook, 2022 & 2030 (In %); Figure 14: China Male Infertility Market 2023-2030 (In $ Million); Figure 15: Japan Male Infertility Market 2023-2030 (In $ Million); Figure 16: India Male Infertility Market 2023-2030 (In $ Million); Figure 17: South Korea Male Infertility Market 2023-2030 (In $ Million); Figure 18: Asean Countries Male Infertility Market 2023-2030 (In $ Million); Figure 19: Australia & New Zealand Male Infertility Market 2023-2030 (In $ Million); Figure 20: Rest Of Asia-pacific Male Infertility Market 2023-2030 (In $ Million)